Sharecast News
23 Jun, 2022 10:21

3i enters exclusive negotiations to sell Havea Group

dl 3i group investment investors infrastructure logo website ftse 100
3i GroupSharecast graphic / Josh White

3i Group announced on Thursday that it, and its co-investor Cathay Capital, have entered into exclusive negotiations for the sale of its investment in Havea Group to funds advised by BC Partners, alongside Havea’s management team.

The company said the proceeds it receives would be at a 50% uplift to its 31 March valuation.

It described Havea as a “leading” European natural healthcare firm, with a consumer-patient-centric approach centred on five strategic brands - Aragan, Biolane, Densmore, Dermovitamina and Vitavea.

3i invested in Havea in 2017, and supported its “transformation” to become a leader in the sector and double in size, reaching €212m sales in 2021.

During the period, Havea delivered double-digit organic growth and completed five acquisitions in five years, “significantly reinforcing” its presence in Italy and Belgium.

In addition, the company simplified its brand portfolio by moving to a consumer-patient-centric approach, and implemented a “complete multichannel strategy” with the launch of direct-to-consumer subscription services.

“The thesis supporting our investment in Havea was to back the global megatrend towards more natural and sustainable healthcare products,” said 3i partner and managing director Rémi Carnimolla.

“Havea benefits from this thanks to its strong innovation culture and willingness to constantly improve and understand the consumer journey.

“Havea’s tremendous development was made possible by Nicolas and his team.”

At 1002 BST, shares in 3i Group were down 0.74% at 1,068.5p.

Reporting by Josh White at Sharecast.com.


News Source: © 2022 Web Financial Group (UK) Limited. All rights reserved and terms of use apply.

Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

The value of investments can fall and you may get back less than you invested.

 

Important Legal Notice about News Sources

Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news articles and we may not share the views of the author or publisher.

We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.

The value of investments can fall and you may get back less than you invested.